Community registry for cancer risk assessment and prevention
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
This study is collecting information from adults at higher risk for cancer to see how we can improve cancer screening and prevention in the community.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hackensack Meridian Health Academic / other |
| Locations | 1 site (Totowa, New Jersey) |
| Trial ID | NCT06804395 on ClinicalTrials.gov |
What this trial studies
This registry collects data from adults at increased risk for cancer to enhance understanding of cancer screening and diagnostics. Participants complete questionnaires and provide consent for data collection related to their cancer risk. The initiative is led by the HMH Hennessey Institute for Cancer Prevention and Applied Molecular Science, aiming to improve early cancer detection and management in the community. By gathering this information, the registry seeks to facilitate better cancer prevention strategies and outcomes.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a personal or family history indicating an increased risk for cancer.
Not a fit: Patients without any known risk factors for cancer or those who do not meet the eligibility criteria may not benefit from this registry.
Why it matters
Potential benefit: If successful, this initiative could lead to improved early detection and management of cancer, ultimately enhancing patient outcomes.
How similar studies have performed: Other studies focusing on community-based cancer screening and risk assessment have shown promise in improving early detection rates.
Eligibility criteria
Show full inclusion / exclusion criteria
* Adults ( 18 and older) * Ability to provide own consent * Must meet at least one of the below criteria, Indicating an increased risk for cancer, any of the following: * Family or personal history suggests a familial/hereditary disorder known or suspected of predisposition to cancer. * Personal factors associated with an increased risk for cancer include benign breast disease, polyps, tobacco use, etc.as defined by the investigator. * Family members of participating individuals. * Any participant in the HICAP program regardless of cancer risk
Where this trial is running
Totowa, New Jersey
- Hennessy Institute for Cancer Prevention and Applied Molecular Medicine — Totowa, New Jersey, United States (Recruiting)
Study contacts
- Principal investigator: Elias Obeid, MD, MPH — Hackensack Meridian Health
- Study coordinator: Lee Ifhar, MSc, CCRP
- Email: Lee.ifhar@hmhn.org
- Phone: 862-657-4227
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.